New responsibilities in the management of colorectal cancer with peritoneal seeding
- PMID: 12449746
- DOI: 10.1081/cnv-120005929
New responsibilities in the management of colorectal cancer with peritoneal seeding
Abstract
The initial dissemination of colon cancer through three routes: the lymphatics, the portal blood, and the peritoneal surfaces. Dissemination to periotoneal surface may be only superficial contamination of the parietal and visceral peritoneum that may be treatable for cure. Unfortunately, surgery may have an adverse impact on peritoneal surface dissemination. Surgical interventions may convert a superficial process into an invasive condition with a greatly reduced prognosis. In patients with peritoneal seedings, peritonectomy procedures and perioperative intraperitoneal chemotherapy should be performed concomitantly. By use of a quantitative scoring system, the mass of cancer present in the abdomen and pelvis at the time of treatment of carcinomatosis correlated directly with survival. Aggressive treatment of patients with peritoneal carcinomatosis requires consideration in the management of colorectal cancer.
Similar articles
-
Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.Dis Colon Rectum. 2000 Oct;43(10):1341-6; discussion 1347-8. doi: 10.1007/BF02236627. Dis Colon Rectum. 2000. PMID: 11052509 Clinical Trial.
-
Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.Dis Colon Rectum. 2015 Aug;58(8):743-52. doi: 10.1097/DCR.0000000000000412. Dis Colon Rectum. 2015. PMID: 26163953
-
A curative approach to peritoneal carcinomatosis from colorectal cancer.Semin Oncol. 2005 Dec;32(6 Suppl 9):S68-73. doi: 10.1053/j.seminoncol.2005.06.009. Semin Oncol. 2005. PMID: 16399436 Review.
-
Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer.World J Surg. 1995 Mar-Apr;19(2):235-40. doi: 10.1007/BF00308632. World J Surg. 1995. PMID: 7754629 Review.
-
Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.J Am Coll Surg. 2006 Dec;203(6):878-86. doi: 10.1016/j.jamcollsurg.2006.08.024. Epub 2006 Oct 25. J Am Coll Surg. 2006. PMID: 17116556
Cited by
-
Cytoreductive surgery and intraoperative intraperitoneal hyperthermic chemotherapy in patients with peritoneal carcinomatosis of colorectal origin.Clin Transl Oncol. 2005 Nov;7(10):421-31. doi: 10.1007/BF02716592. Clin Transl Oncol. 2005. PMID: 16373050 Review.
-
Covering the colon anastomoses with amniotic membrane prevents the negative effects of early intraperitoneal 5-FU administration on anastomotic healing.Int J Colorectal Dis. 2010 Feb;25(2):223-32. doi: 10.1007/s00384-009-0833-9. Epub 2009 Oct 29. Int J Colorectal Dis. 2010. PMID: 19865820
-
Conjugated linoleic acid reduced metastasized LL2 tumors in mouse peritoneum.Virchows Arch. 2006 Sep;449(3):341-7. doi: 10.1007/s00428-006-0249-7. Epub 2006 Aug 8. Virchows Arch. 2006. PMID: 16896890
-
Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report.J Med Case Rep. 2008 Dec 4;2:372. doi: 10.1186/1752-1947-2-372. J Med Case Rep. 2008. PMID: 19055844 Free PMC article.
-
Peritoneal metastasis inhibition by linoleic acid with activation of PPARgamma in human gastrointestinal cancer cells.Virchows Arch. 2006 Apr;448(4):422-7. doi: 10.1007/s00428-005-0110-4. Epub 2005 Dec 16. Virchows Arch. 2006. PMID: 16362414
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical